Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is PPARG rs1801282 CC linked to less favorable insulin sensitivity, and can CAT rs1001179 CT reduce peroxide-handling resilience under oxidative stress?

PPARG rs1801282 CC is associated with less favorable insulin sensitivity, and CAT rs1001179 CT can reduce peroxide-handling resilience under oxidative stress.

PlausibleJuly 27, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

PPARG rs1801282 CC is associated with less favorable insulin sensitivity than the G allele, and catalase rs1001179 CT can reduce peroxide-handling resilience under oxidative stress.

laying out figure…
3 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links PPARG rs1801282 CC with higher insulin resistance-related measures than G allele carriers. It also frames CAT rs1001179 CT as lowering catalase activity, which can limit peroxide clearance when oxidative stress is elevated. Together, these variants are described as affecting metabolic and antioxidant homeostasis.

Verified conclusion

For aging individuals, optimizing metabolic function and antioxidant capacity is critical for maintaining systemic health. The genetic variants PPARG rs1801282 and CAT rs1001179 directly influence baseline insulin sensitivity and the body's primary defenses against oxidative stress.

Insulin sensitivity and metabolic outcomes

  • The PPARG rs1801282 CC (Pro12Pro) genotype is strongly associated with higher fasting insulin levels and higher Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) values compared to G (Ala) allele carriers.
  • In contrast, carriage of the G allele (CG/GG) is linked to a more protective metabolic profile, including an approximate 18% reduction in type 2 diabetes susceptibility and superior improvements in insulin sensitivity following exercise regimens or thiazolidinedione therapy.

Peroxide-handling and antioxidant resilience

  • The catalase (CAT) rs1001179 CT genotype leads to moderately reduced or intermediate erythrocyte catalase enzyme activity compared to the homozygous CC wild-type.
  • Because catalase’s primary biological role is converting hydrogen peroxide ($H_2O_2$) into water and oxygen, this reduction directly limits the capacity to rapidly degrade peroxide.
  • While alternative pathways (such as glutathione peroxidase and peroxiredoxins) maintain baseline homeostasis, these redundant systems can become overwhelmed during periods of elevated reactive oxygen species (ROS) load. Under physiological stressors like chronic inflammation or hyperglycemia, the lower enzymatic capacity of the CT genotype allows hydrogen peroxide to persist, resulting in increased oxidative damage.

Bottom line

  • Carrying the PPARG rs1801282 CC genotype and the CAT rs1001179 CT genotype collectively compromises baseline metabolic homeostasis and impairs the cellular capacity to clear reactive oxygen species under oxidative stress, suggesting a benefit from proactive metabolic and antioxidant support.

References

  1. The PPARgamma Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjects - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  2. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  3. Association of PPARG rs 1801282 C>G polymorphism with risk of ... — pmc.ncbi.nlm.nih.gov ↗
  4. PPARG (Pro12Ala) genetic variant and risk of T2DM — nature.com ↗
  5. The PPARG Pro12Ala Polymorphism Is Associated With a Decreased Risk of Developing Hyperglycemia Over 6 Years and Combines With the Effect of the APM1 G-11391A Single Nucleotide Polymorphism: The Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study — diabetesjournals.org ↗
  6. Human Catalase, Its Polymorphisms, Regulation and ... — fb.cuni.cz ↗
  7. Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Association of Hormone Replacement Therapy with Postmenopausal Breast Cancer Risk — aacrjournals.org ↗
  8. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli — pmc.ncbi.nlm.nih.gov ↗
  9. The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of Cancers — pmc.ncbi.nlm.nih.gov ↗
  10. The rs1001179 SNP and CpG methylation regulate catalase ... — link.springer.com ↗
  11. Evolution of catalases from bacteria to humans. — pmc.ncbi.nlm.nih.gov ↗
  12. Association of Catalase and Glutathione Peroxidase 1 Polymorphisms with Chronic Hepatitis C Outcome: CAT/GPX1 polymorphisms and HCV outcome — onlinelibrary.wiley.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→